Welcome Message

The world's most awaited Pharma event and you're invited to attend the “International Conference on Current Advantages in Pharmaceutical Industry and Development”. The conference will be held in October 17-18, 2023 Paris, France, and will feature timely Keynote speeches, Oral talks, Poster presentations, and Exhibitions. This strategic conference will have in-depth talks and interactive sessions that will allow attendees to network with like-minded individuals and discuss how to tackle current obstacles in pharmaceutical product development and synthesis. This year's focus will be on the most recent breakthroughs in pharmaceutical sciences, clinical research, and allied fields, as well as research and development. Pharmaceutical Industry 2023 is a cluster of all European Pharma conferences that has been carefully developed. "Pharma Development" is the main focus of this Pharma conference.The Current Pandemic Situation, this covers a wide range of crucial topics.

Meet your target audiences from all over the world who are interested in learning about Pharma laws, licenses, and approvals at Pharmaceutical Industry 2023. This conference will provide you with the finest opportunity to reach the largest number of Pharma field participants.

Theme: "Novelties in Pharmaceutical and Medical Sciences" will be featuring the world class keynote talk, speakers presenting clinical studies, oral and poster presentation with interactive networking session and workshops.

Why to Attend

This year, we will have more senior speakers, who will be joining us from pharmaceutical giants. They're coming to share their experience with us and ensure you can maximize your knowledge.

They also want to join us because they know how important it is to have your questions answered. In light of all that's happening in the Pharmaceutical industry, this year delivers more case studies for you to gain first-hand experience on developing your drugs, clinical trials, and we will be introducing think tank sessions to discuss and debate challenges in more detail with key decision makers. These sessions will bring you constructive networking possibilities so you return to work with practical solutions for your challenges.

Over 50+ organizations and international pavilions will be exhibiting at the Pharma Europe 2020 conference.  Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

Target Audience

• Directors, CEO’s of Organizations
• Business Development Managers
• Chief Scientific Officers
• R&D Researchers from Pharma Industries
• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Patent Attorneys
• Investment Analysts
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Bio instruments Professionals
• Bio-informatics Professionals
• Software development companies
• Research Institutes and members
• Supply Chain companies
• Manufacturing Companies
• CRO and DATA management Companies
• Training Institutes

Business Entrepreneurs All specialists inside the field of Pharmaceutical including its subspecialties

Sessions Tracks

Track 1: Digital Parma

Some people believe that digital capabilities are critical not only for pharmaceutical companies' ability to improve how they roll out new products, but also for increasing the pharmaceutical industry's contribution to health care by allowing it to provide innovative services to improve patient outcomes. To raise Parma's perceived value in the health-care system, the industry is working to meet the demands of all stakeholders, including health, patients, and payers. Meanwhile, the pharmaceutical industry's mentality is evolving from vertically organized divisions to cross-functional collaboration.

Related Societies:

Societies in the USA: Industry Pharmacists Organization | American Pharmacists Association | American Association of Pharmaceutical Scientists (AAPS) |American Statistical Association | Controlled Release Society | Society for Biomaterials | American Chemical Society |American Coatings Association | Parenteral Drug Association | American Association of Pharmaceutical Scientists (AAPS) Parenteral Drug Association (PDA) | The International Society of Biopharmaceutical Statistics.

Societies in Europe: European Biopharmaceutical Enterprises | the Danish Society for Biopharmaceutical Statistics | European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association

Societies in Asia and Pacific: Chinese Biopharmaceutical Association | Pharmaceutical Society of Australia | Pharmacy Guild of Australia | Chinese American Biopharmaceutical Society

Track 2: R&D Progress: The Path to New Medicines

To deal with the innovation dilemma (patent loss, pipeline drying up), big pharmaceutical corporations use innovative business models to boost R&D and innovation productivity. As a result of these challenges, major corporations have had to alter or reinvent their business models in order to maintain value creation through R&D and innovation. However, to our knowledge, there is still a dearth of understanding about the "strategic alignment" of these organizational changes, as well as how organizational members view them.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED.

Track 3: Clinical Pharmacy and Therapeutics

The chemical qualities, formulation, and method of administration of a medicine determine its absorption. Dosage forms (e.g., tablets, capsules, and solutions), which include the medicine and other substances, have been devised to be taken via a variety of methods (e.g. oral, buckle, sublingual, rectal, parenteral, topical, inhalational). Medicine should be able to be absorbed regardless of the mode of delivery.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (Ephesus), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 4: Pharmaceutical sciences

Pharmaceutical sciences encompass a wide range of scientific disciplines that are essential for the discovery and development of new medications and cures. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to better understand how to deliver drugs to the body and translate that knowledge into new and improved therapies for human disease. Many of the institutes' internationally renowned faculty contributes to the field by investigating the underlying mechanisms of drug interactions with the human body and developing advanced synthetic or biologically-derived materials that can modulate these interactions in the search for better and safer therapies and drug products.

Related Societies:

Societies in USA: American Society of Pharmacognosy (ASP) | Phytochemical Society of North America (PSNA) | the Herb Society of America | American Herbal Products Association (AHPA)

Societies in Europe: Phytochemical Society of Europe (PSE) | Society for Medicinal Plant and Natural Product Research | European Herbal and Traditional Medicines Association (EHTPA)

Societies in Asia and Pacific: The Asian Society of Pharmacognosy (ASP) | Society of Pharmacognosy, Malaysian Natural Product Society (MNPS) | The Japanese Society of Pharmacognosy | Australian Society of Plant Scientists

Track 5: Pharmaceutical Nanotechnology

Pharmaceutical nanotechnology is concerned with the development of personalized drug delivery systems using emerging technological technologies. The rate of absorption, distribution, metabolism, and excretion of the drug or other relevant chemical components in the body is influenced by the drug delivery mechanism. Furthermore, the drug delivery method enables the medication to attach to its target receptor and alter the signaling and activity of that receptor. Pharmaceutical nanotechnology encompasses the use of nanomaterials in pharmacy as well as technologies such as medication delivery, diagnostics, imaging, and biosensors.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (Ephesus), Pharmaceutical Group of the European Union (PGEU), Pharmaceutical Society of Ireland, 

Track 6: Entrepreneurs Investment 

A platform that connects Entrepreneurs, Proposers, and Investors from all around the world. Its goal is to build and facilitate the most efficient and practical meeting space for people to engage in global business talks, appraisal, and execution of innovative business ideas. An investor may be able to identify the best investment possibilities throughout the world that offer a good return on investment.

Related Societies:

Societies in the USA: American College of Clinical Pharmacology | American Society for Clinical Pharmacology and Therapeutics| American Neurological Association(ANA) |  American Society of Neuroimaging | American Board of Psychiatry and Neurology (ABPN) | American Academy of Neurology (AAN)

Societies in Europe: The Federation of European Pharmacological Societies | The European Association for Clinical Pharmacology and Therapeutics (EACPT) |  The European Behavioral Pharmacology Society (EBPS) | British Pharmacological Society

Societies in Asia and Pacific: Korean Society of Pharmacology | Malaysian Society of Pharmacology and Physiology (MSPP) | Pharmacological Society of Taiwan | Japanese Pharmacological Society

Track 7: The Globalized Pharmaceutical Industry

The Globalized Parma Sector is based on gaining information on changing competition structure and increased competitiveness, lack of brand new products despite increased investments in R&D (Research& Development), increased importance of regulatory issues (registrations, intellectual property rights, litigation), and fast consolidation and concentration of the global pharmaceutical industry.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU), Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society.

Track 8: Drug Discovery 

Drug discovery is the process of discovering novel candidate pharmaceuticals in the domains of medicine, biotechnology, and pharmacology. Modern drug discovery entails identifying screening hits, medicinal chemistry, and optimization of those hits to improve affinity, selectivity (to lower the risk of adverse effects), efficacy or potency, metabolic stability (to extend the half-life), and oral bioavailability.

Related Societies:

Societies in the USA: Accreditation Council for Pharmacy Education | American Institute of the History of Pharmacy | American Society of Health-System Pharmacists | American Society of Consultant Pharmacists(ASCP)

Societies in Europe: European Medicines Agency | Federal Agency for Medicines and Health Products (FAGG) | Danish Health and Medicines Authority (SST) | Bulgarian Drug Agency (BDA) | Federal Institute for Drugs and Medical Devices (BfArM) | National Organization for Medicines (EOF)

Societies in Asia and Pacific: China Food and Drug Administration (CFDA) | Drug Office - Department of Health | Pharmaceuticals and Medical Devices Agency (PMDA) | Ministry of Food and Drug Safety (MFDS) | Pharmacy and Drug Control

Track 9: Drug Development

Once a lead molecule has been identified through the drug discovery process, drug development focuses on bringing a new pharmaceutical medicine to market. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as an investigational new drug application with the US Food and Drug Administration to begin human clinical trials, and possibly obtaining regulatory approval with a new drug application to market the drug.

Related Societies:

The International Society for Pharmaceutical Engineering (ISPE), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED

Track 10: Pharmaceutical Engineering

Pharmaceutical engineering is concerned with pharmaceutical science and technology, which includes the creation and manufacture of pharmaceutical products, procedures, and components (i.e. drugs & biologics). While the development of pharmaceutical products requires many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, and so on), the subfield of "pharmaceutical engineering" has only recently emerged as a distinct engineering discipline.

Related Societies:

Societies in the USA: American Institute of Chemists | American Society for Mass Spectrometry | American Association for Clinical Chemistry | American Crystallographic Association | American Society for Biochemistry and Molecular Biology | Brazilian Chemical Association

Societies in Europe: European Association for Chemical and Molecular Sciences | European Association of Employed Community Pharmacists in Europe | European Pharmaceutical Union | Estonian Chemical Society

Societies in Asia and Pacific: Chemical Research Society of India | Chemical Society of Thailand | Chemical Society of the South Pacific | Chemical Society of Turkey | Chinese Chemical Society | Chinese-American Chemical Society

Track 11: Pharmaceutical Supply Chain Optimization

The integration of important business operations across the supply chain for the aim of providing value for customers and stakeholders is known as supply chain management (SCM). Supply chain management, in fact, is a business model that connects supply and demand within and across enterprises. Supply chain management is defined by the Council of Supply Chain Management Professionals as the planning and management of all activities related to sourcing, procurement, conversion, and all logistics activities. Eliminating bottlenecks, balancing lowest material cost with transportation, optimizing manufacturing flow, maintaining the right mix and location of factories and warehouses, vehicle routing analysis, dynamic programming, and efficient use of capacities, inventories, and labor are some of the main aspects of supply chain optimization.

Related Societies:

Societies in the USA: Controlled Release Society | Society for Biomaterials | American Chemical Society | American Coatings Association | Parenteral Drug Association | American Association of Pharmaceutical Scientists (AAPS)

Societies in Europe: The British Society for Nanomedicine, | European Society for Biomaterials | Royal Pharmaceutical Society of Great Britain | Turkish Pharmacists Association

Societies in Asia and Pacific: Pharmaceutical Society of Korea | Pharmaceutical Society of Australia | Pharmacy Guild of Australia

Track 12: Pharmaceutical Regulatory Requirements

There are numerous reasons for expanding merchandise development outside of mature, developed economies (e.g., the EU and hence the US), and the majority of them are based on the growing markets' large population and market potential. FDA guidelines for clinical research and pharmaceutical development is becoming increasingly international in nature, with a focus on emerging markets that can help with patient outcomes as well as overall development costs and schedules.

Related Societies:

The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The European Personalised Medicine Association EPEMED, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU).

Track 13: Pharmaceutical Packaging Advances

During storage, transit, exhibition, and until the product is safely consumed, packaging plays a crucial function in providing protection, presentation, convenience, identity information, and compliance. Packaging can be thought of as a technique for getting a product from the producer to the customer safely. The focus of the track is on contemporary advancements in packaging technologies and materials. Many types of symbols for package labeling should be standardized on a national and worldwide level. Product certificates, trademarks, and proof of purchase are all represented by symbols on packaging.

Related Societies:

European Federation of Pharmaceutical Industries and Associations (EFPIA) Pharmaceutical Society https://pharmaceuticalindustry.pharmaceuticalconferences.com/abstract-submission.phpof Ireland, the International Society for Pharmaceutical Engineering (ISPE), the), the European Generic Medicines Association (EGA), the European Personalized Medicine Association EPEMED.

Market analysis

Pharmaceutical Sciences Market Research

The International Pharmaceutical Federation's (FIP) Board of Pharmaceutical Sciences (BPS) has produced a vision for pharmaceutical sciences in 2020. By 2025, the worldwide pharmaceutical market is expected to reach $10.27 billion. Because of the rising frequency of Adverse Drug Reaction, the market is predicted to develop at a 13.1 percent CAGR. ADRs are a major driver of the pharmaceutical market's expansion. The FDA received nearly 253,017 major adverse events and 44,693 deaths related to adverse medication interactions in 2015. (ADRs). This demonstrates the potential for safety and pharmaceutical services to be in demand. The graph depicts the global pharmaceutical market's predicted growth by regional group between 2018 and 2023. During this time, the pharmaceutical market is predicted to develop at a compound annual growth rate of 6 to 9%.

This statistic depicts the global pharmaceutical market's predicted growth from 2016 to 2021, as measured by the compound annual growth rate (CAGR) and grouped by geographical submarkets. North America is predicted to increase at a CAGR of 4.3 percent.

Natural and plant-derived pharmaceuticals had a global market value of $23.2 billion in 2013 and $24.4 billion in 2014. With a Compound Annual Growth Rate (CAGR) of 6.6 percent from 2015 to 2020, the total market is estimated to reach $35.4 billion in 2020.

According to the World Health Organization, pharmaceuticals had a global market worth $300 billion in 2015. By 2018, the global pharmaceutical market is estimated to exceed $400 billion. Prescription medicine sales are expected to expand at a healthy 6.5 percent (CAGR) through 2022, reaching $1.06 trillion. Orphan pharmaceuticals will account for 32% of the increase in sales in 2022 (+$95 billion).